Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting1
Completed1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting125%
completed125%
not_yet_recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

NCT04964310
not_yet_recruiting

mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism

NCT06457646
unknown

Pharmacogenetics of Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod

NCT05516303
completednot_applicable

Effectiveness of Muscular Work and Genetic Variants in Strength Gain of Ischiofemoral and Quadriceps

NCT03973060

Clinical Trials (4)

Showing 4 of 4 trials
NCT04964310

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

Recruiting
NCT06457646

mRNA Expression and Genetic Polymorphisms Affecting DRD3 (rs6280) and HTR2A (rs6313) in Bruxism

Not Yet Recruiting
NCT05516303

Pharmacogenetics of Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod

Unknown
NCT03973060Not Applicable

Effectiveness of Muscular Work and Genetic Variants in Strength Gain of Ischiofemoral and Quadriceps

Completed

All 4 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
4